Annual CFI
-$14.88 M
-$14.78 M-14349.51%
31 December 2023
Summary:
X4 Pharmaceuticals annual cash flow from investing activities is currently -$14.88 million, with the most recent change of -$14.78 million (-14349.51%) on 31 December 2023. During the last 3 years, it has fallen by -$14.27 million (-2320.00%). XFOR annual CFI is now -154.65% below its all-time high of $27.23 million, reached on 31 December 2019.XFOR Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$15.93 M
-$112.79 M-116.45%
30 September 2024
Summary:
X4 Pharmaceuticals quarterly cash flow from investing activities is currently -$15.93 million, with the most recent change of -$112.79 million (-116.45%) on 30 September 2024. Over the past year, it has dropped by -$11.10 million (-229.59%). XFOR quarterly CFI is now -116.45% below its all-time high of $96.86 million, reached on 30 June 2024.XFOR Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$70.78 M
-$10.77 M-13.21%
30 September 2024
Summary:
X4 Pharmaceuticals TTM cash flow from investing activities is currently $70.78 million, with the most recent change of -$10.77 million (-13.21%) on 30 September 2024. Over the past year, it has increased by +$85.66 million (+575.56%). XFOR TTM CFI is now -13.21% below its all-time high of $81.55 million, reached on 30 June 2024.XFOR TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XFOR Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -229.6% | +575.6% |
| 3 y3 years | -2320.0% | -10000.0% | +10000.0% |
| 5 y5 years | -154.7% | -10000.0% | +159.9% |
XFOR Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | <-9999.0% | at low | -116.5% | at low | -13.2% | +450.5% |
| 5 y | 5 years | -154.7% | at low | -116.5% | at low | -13.2% | +450.5% |
| alltime | all time | -154.7% | at low | -116.5% | at low | -13.2% | +450.5% |
X4 Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$15.93 M(-116.4%) | $70.78 M(-13.2%) |
| June 2024 | - | $96.86 M(-1920.0%) | $81.55 M(-503.8%) |
| Mar 2024 | - | -$5.32 M(+10.1%) | -$20.20 M(+35.7%) |
| Dec 2023 | -$14.88 M(>+9900.0%) | -$4.83 M(-6.3%) | -$14.88 M(+47.6%) |
| Sept 2023 | - | -$5.16 M(+5.6%) | -$10.08 M(+104.3%) |
| June 2023 | - | -$4.88 M(>+9900.0%) | -$4.94 M(+5384.4%) |
| Mar 2023 | - | -$9000.00(-73.5%) | -$90.00 K(-12.6%) |
| Dec 2022 | -$103.00 K(-83.3%) | -$34.00 K(+277.8%) | -$103.00 K(+25.6%) |
| Sept 2022 | - | -$9000.00(-76.3%) | -$82.00 K(-11.8%) |
| June 2022 | - | -$38.00 K(+72.7%) | -$93.00 K(-34.0%) |
| Mar 2022 | - | -$22.00 K(+69.2%) | -$141.00 K(-77.1%) |
| Dec 2021 | -$615.00 K(-54.8%) | -$13.00 K(-35.0%) | -$615.00 K(-32.0%) |
| Sept 2021 | - | -$20.00 K(-76.7%) | -$904.00 K(-34.5%) |
| June 2021 | - | -$86.00 K(-82.7%) | -$1.38 M(+5.9%) |
| Mar 2021 | - | -$496.00 K(+64.2%) | -$1.30 M(-4.3%) |
| Dec 2020 | -$1.36 M | -$302.00 K(-39.1%) | -$1.36 M(+31.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | -$496.00 K(+5411.1%) | -$1.04 M(-482.0%) |
| June 2020 | - | -$9000.00(-98.4%) | $272.00 K(+0.4%) |
| Mar 2020 | - | -$555.00 K(-2742.9%) | $271.00 K(-99.0%) |
| Dec 2019 | $27.23 M(>+9900.0%) | $21.00 K(-97.4%) | $27.23 M(-0.0%) |
| Sept 2019 | - | $815.00 K(-8250.0%) | $27.25 M(+3.1%) |
| June 2019 | - | -$10.00 K(-100.0%) | $26.42 M(+0.1%) |
| Mar 2019 | - | $26.41 M(>+9900.0%) | $26.41 M(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $34.00 K(-585.7%) | $0.00(-100.0%) |
| Sept 2018 | - | -$7000.00(-74.1%) | -$17.00 K(-39.3%) |
| June 2018 | - | -$27.00 K(-258.8%) | -$28.00 K(-33.3%) |
| Dec 2017 | -$42.00 K(-42.5%) | $17.00 K(-194.4%) | -$42.00 K(-28.8%) |
| Sept 2017 | - | -$18.00 K(-25.0%) | -$59.00 K(+43.9%) |
| June 2017 | - | -$24.00 K(+41.2%) | -$41.00 K(+141.2%) |
| Mar 2017 | - | -$17.00 K | -$17.00 K |
| Dec 2016 | -$73.00 K(-70.4%) | - | - |
| Dec 2015 | -$247.00 K | - | - |
FAQ
- What is X4 Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for X4 Pharmaceuticals?
- What is X4 Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for X4 Pharmaceuticals?
- What is X4 Pharmaceuticals quarterly CFI year-on-year change?
- What is X4 Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for X4 Pharmaceuticals?
- What is X4 Pharmaceuticals TTM CFI year-on-year change?
What is X4 Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of XFOR is -$14.88 M
What is the all time high annual CFI for X4 Pharmaceuticals?
X4 Pharmaceuticals all-time high annual cash flow from investing activities is $27.23 M
What is X4 Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of XFOR is -$15.93 M
What is the all time high quarterly CFI for X4 Pharmaceuticals?
X4 Pharmaceuticals all-time high quarterly cash flow from investing activities is $96.86 M
What is X4 Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, XFOR quarterly cash flow from investing activities has changed by -$11.10 M (-229.59%)
What is X4 Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of XFOR is $70.78 M
What is the all time high TTM CFI for X4 Pharmaceuticals?
X4 Pharmaceuticals all-time high TTM cash flow from investing activities is $81.55 M
What is X4 Pharmaceuticals TTM CFI year-on-year change?
Over the past year, XFOR TTM cash flow from investing activities has changed by +$85.66 M (+575.56%)